A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTXTIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT)

Administered By

Awarded By

Contributors

Start/End

  • July 12, 2022 - June 30, 2027